Agenda
TUESDAY, MAY 21, 2024
- 09:30 - 09:45 | Welcome by Conference Chairpersons
- 09:45 - 10:15 | Plenary: Dr. Anula Jayasuriya, MD, PhD, Partner, Kidron Capital Assets
- 10:15 - 10:45 | Plenary: Aharon (Ronny) Gal, PhD, Chief Strategy & Growth Officer, Member of the Executive Committee, Novartis, Five thoughts about the future of the pharmaceutical industry
- 10:45 - 11:15 | Plenary: Gil Bar-Nahum, PhD, Managing Director, Jefferies International
- 11:15 - 11:45 | Coffee Break
HALL A
11:45 - 13:45
Why does cardiovascular disease remain the number ONE target for MedTech innovation?
Moderators: Dr. David Israeli, MD, Chairman & CEO, Magenta Medical
Amir Gross, Co-Founder & CEO, Cardiovalve
Keynote: Doron Harlev, Co-Founder & CEO, Affera, “Building Affera from an idea to a remarkable M&A event”
Keynote: Beni Surpin, Partner, Goodwin Procter LLP. “The Secret Recipe to Mega Success in the Cardiovascular MedTech Space – From a Legal Perspective”
Company Presenters:
Dr. David Israeli, MD, Chairman & CEO, Magenta Medical, “Magenta Elevate: High Output, Low French Size Percutaneous Mechanical Circulatory Support”
Ronen Eckhouse, CEO, Rapid Medical Ltd. “Rapid Medical is Expanding What’s Possible in Stroke Treatment”
Amir Danino, Founder & CEO, Innoventric, “Innoventric Heterotopic Cross-Caval Portfolio”
Dr. David Meerkin, MD, CMO, Valcare, Althea Medical, “The Friendly Giant: Opportunities for Althea Medical’s Pulmonary Embolectomy Solutions”
Boaz Manash, CEO, Cardiac Success, ” Vsling: Transcatheter Ventricular Repair Device for Heart Failure Patients”
Prof. Haim Danenberg, CMO, Append Medical, “Next generation for LAA exclusion”
Eyal Baror, CEO, Innovalve, “Innovalve TWIST Technology:A Novel Approach to TranscatheterMitral Valve Replacement Challenges”
HALL B
11:45 - 13:45
Evolving trends in Cancer Therapeutics
Moderator: Tehila Ben Moshe, PhD, Founder, CEO & Chairman, Biond Biologics
Keynote: Dr. Rafaèle Tordjman, MD, PhD Founder & CEO, Jeito Capital
Keynote: Michael A. Margolis, Head of Healthcare Life Sciences, Co-Head of Health, Oppenheimer, “Current trends & what’s hot in the Cancer Therapeutics space from a capital markets and M&A perspective”
Company Presenters:
Irit Carmi-Levy, General Manager & CSO, Aummune Tech, “A new class of individualized immunotherapy to treat solid tumors”
Pini Tsukerman, CSO, Nectin TX, “Pushing the Boundaries of Cancer Immunotherapy with Novel Targets, and Therapeutic Approaches”
Yaron Pereg, CEO, KAHR Medical Ltd
Motti Hakim, PhD, VP R&D, Biond Biologics, “BND-67 a new approach for targeting CD28”
Peleg Rider, PhD, Co-Founder & VP of Immunology, Gilboa Therapeutics, “SolidT, a platform technology for targeting solid tumors with safer and more “
Prof. Amnon Peled, CSO, AlonBio, “Targeting migration, survival and immune response pathways in cancer”
HALL C
11:45 - 13:45
Unlocking a new era of brain health innovation
Michel Habib, Co-Founder, Managing General Partner, ALIVE Israel HealthTech Fund
- 13:45 - 15:00 | Lunch
HALL A
15:00 - 17:00
Digital Biomarkers & Digital Pathology: new tools to enhance therapy
Moderator: Avi Viedman, Co-Founder & CEO, Nucleai
Keynote: Dr. Iris Barshack, MD, Head of Pathology Institute, Chair of the Israeli Association of Pathologists, Sheba Medical Center, “Innovation in digital pathology for clinical practice”
Company Presenters:
Boaz Brill, PhD, Pentaomix, Co-Founder &CEO, “Multiplex Imaging for Better Cancer Diagnosis“
Danit Oz Levi, PhD, Head of Scientific & Clinical Affairs,Imagene, “How can Immediate Oncology Intelligence Guide Patients’ Optimal Cancer Treatment?”
Issar Yazbin, VP Product Manager, Ibex Medical Analytics, “Impacting Patient Outcomes with Trusted Cancer Diagnostics”
Dr. Amy Meitus, MD, Scopio Labs, “Revolutionizing first line hematology testing with Full Field technology”
Gabe Siegel, Founder & CEO, Augmentiqs, “What’s slowing down digital pathology? ”
Tuvik Beker, PhD, Pangea Biomed, “”Inferring gene expression from slide images can be used to predict treatment outcomes”
Dr. Michele Bentata, MD, SVP, Pharma Business Development, Owkin, “Digital Biomarkers & Digital Pathology:New tools to enhance therapy”
HALL B
15:00 - 17:00
Next generation of genetic medicine
Moderators: Yael Gruenbaum Cohen, DMD, PhD, Venture Partner & Head, aMoon Velocity & aMoon Alpha
Prof. Yaniv Erlich, CEO & Co-Founder, Eleven Therapeutics
Keynote: Dr. Yael Weiss, MD, PhD, Mahzi Therapeutics
Company Presenters:
Nir Skalka, PhD, CSO, Circuit Bio, “Cancer immunotherapy using highly selective gene circuits”
Ram Waisbourd, CEO, Trojan Cells, “Trojan Cells : A New Cell Therapy Modality for Targeted Production of Therapeutics in a Disease Microenvironment”
Yogev Debbi, CEO, Mana.bio, “Utilizing Machine Learning Approach to Unlock Extra-Hepatic Delivery of Lipids Nanoparticles”
Gili Hart, PhD, CEO, SpliSense, “SpliSense – RNA Based Platform for Pulmonary Diseases”
Roee Farber, PhD, CEO, ZipBio, “ZipBio: Compressing biology to develop the next generation of gene therapies”
Prof. Yuval Tabach, Co-Founder, Professor, The Deep Genomic Laboratory, Hebrew University medical school, Department of Developmental Biology & Cancer Research, ” Leverage the greatest R&D engine ever created to deliver novel precision Oncology”
Yair Benita, PhD, CTO, AION Labs
HALL C
15:00 - 17:00
What can we do to make healthier aging a reality?
Moderator: Prof. Varda Shalev, MD, MPA, Managing Partner, Team8 Health
Keynote: Dr. Josef Coresh, MD, PhD, Founding Director, Optimal Aging Institute, Professor of Population Health and Medicine, NYU Grossman School of Medicine
This keynote will be a “fireside chat” format led by Prof. Varda Shalev, a family physician with over 30 years of experience. It will feature Prof. Naama Sabar-Ben Yehoshua, an inspiring 85-year-old advocate for healthier aging, and her son, Dr. Ron Sabar, founder and CMO of Sabar Health. They will discuss their perspectives on aging from both medical and personal viewpoints.
Company Presenters:
Rotem Bar-Or, PhD, Head, Academic Partnerships & IP, Neuralight
Rami Kirshblum, Co-Founder & CEO, Uniper Care
Sheli Bekel Sela, VP R&D, SensiAI
Eyal Lewin, CEO, NYX Technologies
Dr. Hilla Ben Pazi, MD, CEO, Avertto
Tal Shapsa Heiman, Co-Founder & CEO, Epilog
WEDNESDAY, MAY 22, 2024
- 09:30 - 09:50 |Plenary: Dror Bin, Chief Executive Officer, Israel Innovation Authority
- 09:50 -10:20 |Plenary: Richard Francis, President and Chief Executive Officer, Teva Pharmaceuticals
- 10:20 - 10:50 |Plenary: Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals
- 10:50 - 11:20 | Coffee Break
HALL A
11:20 - 13:20
Liquid biopsy & Diagnostics: Getting closer to transforming early detection and disease management
Moderators:
Dr. Ofer Sharon, MD, CEO, OncoHost
Yaron Daniely, PhD, General Partner, aMoon
Keynote: Stanley Lapidus, Inventor & Entrepreneur, Founding CEO, Cytyc Corp., ThinPrep & EXACT Sciences
Company Presenters:
Prof. Tomer Shlomi, MetaSight, “Population-scale molecular diagnostics”
Michal Mark Daniely, PhD, Founder & CEO, Early Labs, “A urine test for the early detection of lung cancer using AI and animal biosensors”
Dr. Aharona Shuali, MD, VP Medical, Nucleix, “Bringing liquid biopsy to early detection of cancer-Nucleix’ journey”
Inbal Zafir-Lavie, PhD, CEO & Co-Founder, NEVIA
Dr. Ofer Sharon, MD, CEO, OncoHost, “The PROphet Liquid Biopsy Platform”
Vered Bar, PhD, VP R&D, CureResponse Tech, “Optimizing Anticancer Treatment Management with a Functional Patient Derived Explants (PDE) Assay”
Olga Nissan, PhD, Co-Founder & CEO, Protica Bio, “Predicting Cancer Immunotherapy Response with AI-Enhanced Proteomics”
HALL B
11:20 - 13:20
Is it time to celebrate the rebound of the medical device sector?
Moderators:
Gilad Glick, VP, JJDC Medtech, Johnson & Johnson Innovation Fund, “MedTech Acquisitions – Is commercialization the new expectation ?”
Eyal Lifschitz, General Partner & Co-Founder, Peregrine Ventures
Keynote: Jon Salveson, Vice Chair, Piper Sandler, “Getting practical: The fate of nutracueticals/bioactives in our body – Histological Point Of View”
Ronen Segal, CTO, AlphaTau Medical
Benny Dilmoney, CEO & Founder, Magneto Thrombectomy Solutions
Illan Uchitel, CEO & Co-Founder, CAPS Medical
Ron Aginsky, Co-Founder & President, FUSMobile
Discure Techologies TBD
BrainsWay TBD
BioBeat TBD
HALL C
11:20 - 13:20
Is AI revolutionizing drug discovery and clinical development?
Moderators:
Anat Cohen Dayag, PhD, President & CEO, Compugen
Dan Goldstaub, PhD, Scientific Co-Founder, Phase V
Keynote: Dr. Eric A. Hughes, MD, PhD, Executive Vice President, Global R&D & Chief Medical Officer, Teva Pharmaceuticals
Keynote: Guy Hadari, PhD, SVP, Global CIO, Biogen
Company Presenters:
Dan Goldstaub, PhD, Scientific Co-Founder, Phase V, “Adaptive Clinical Trials and Tools to Support Them”
Anat Cohen-Dayag, PhD, President & CEO, Compugen, ” Transforming patient lives by developing first-in-class therapeutics based on Compugen’s computational target discovery platform”
Tali Raveh-Sadka, PhD, Director of Computational Biology, Immunai
Isaac Bentwich, CEO, Quris AI
Yanay Ofran, PhD, Founder & CEO, Biolojic Design
Doron Lipson, CSO, Ultima Genomics
Yochi Slonim, Co-Founder & CEO, Anima, “Has AI revolutionized drug discovery and clinical development”
- 13:20 - 14:30 | Lunch
HALL A
14:30 - 16:30
“NUTRItech” is the name of the game"
Moderator:
Tammy Meiron, PhD, Fresh Start FoodTech Incubator
Keynote: Prof. Uri Lesmes, Associate Professor, Technion – Israel Institute of Technology, “The effect of nutrients on our body – an
updated point of view”
Company Presenters:
Tsipi Shoham, PhD, Co-Founder & CEO, Green Onyx
Zohar Gavish, PhD, Founder & CEO, Gavish Research Services, “Getting Practical:
The Fate of Nutracueticals/Bioactives in Our Body – Histological Point of View”
Yochi Hagay, PhD, Co-Founder & CTO, Bio-Harvest Sciences
Zakhar (Zacki) Nudelman, PhD, Chief Business Officer & Director of Scientific Affairs,
SolveEat, “Food as Medicine: The Industrial Frontier of Herbal Remedies”
Yael Kuperman, PhD, Co-Founder & CTO, ANeustart, “Feed your brain: is there a
place for a nutrient-based therapy for autism”
David Gordon, Strategic Advisor, MakeSense Digital Health, “Accurate & truly automated
meal diaries: breaking the glass ceiling of all diets”
HALL B
14:30 - 16:30
The heart, the liver, and the brain in concert: a year of revolutions in the cardiometabolic space
Moderator:
Iris Grossman, PhD, CThO, Eleven Therapeutics
Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals
Opening: Iris Grossman, PhD, CThO, Eleven Therapeutics
Keynote: Dr. Mitchell Steiner , M.D., F.A.C.S., Chairman, President, & Chief Executive Officer, Veru Inc, “Make GLP-1 weight loss drugs more effective and precise — get greater fat loss by preserving muscle mass and function”
Keynote: Ram Weissbourd, ex-COO/CBO, 89Bio, “Dawn of a New Era in the Treatment of Fatty Liver Disease”
Keynote: Prof. Yossi Tam, Professor, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Center for Nanoscience & Nanotechnology, “From Disappointment to Triumph: Cannabinoids’ Resurgence in Metabolic Syndrome Treatment”
Panel discussion, moderated by Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron Pharmaceuticals:
Adi Mor, PhD, CEO, Chief Scientific Officer and Co-Founder, Chemomab, “Pioneering Innovative Treatments for Inflammatory-Fibrotic Diseases”
Kfir Umansky, PhD, Co-Founder, Head of R&D, Principal Investigator, Velakor, “Velakor- using lessons from neonatal cardiac regeneration to repair the broken heart”
Prof. Moshe Mittleman, CSO, Cannalean Biotechs, “Attacking World Enemy – Lowering Lipids”
Maya Cohn Adulamy, Executive Director, Innovation & Head of Israel, Valo, “Reimagining Cardiovascular drug discovery and clinical diagnostics with real-world Data”
Eran Blaugrund, PhD, VP R&D, Raziel Therapeutics, “A novel small molecule, RZL-012, for focal fat reduction”
Closing by Moderators
HALL C
14:30 - 16:30
Women’s Health: Cutting-edge innovation to tackle collective pain points
Moderators:
Avital Adler, PhD, Principal, aMoon Edge
Inbal Zafir Lavie, PhD, CEO & Co-founder, NEVIA
Keynote: Dr. Anula Jayasuriya, MD, PhD, Co-Founder and Managing Director, Kidron Capital Assets, “Gender Oriented Health”
Keynote: Stanley Lapidus, Inventor & Entrepreneur, Board Chairman & Board Member, Founding CEO, Cytyc Corp., ThinPrep & EXACT Sciences, “Among the greatest triumphs in women’s health: The pap test and mammography”
Company Presenters:
Miriam Oron, PhD, CEO & Co-Founder, DermAb.io, “Connecting the Dots: Skin Biomarkers, Women’s Physiology, and Autoimmune Diseases”
Shlomit Steinberg-Koch, CEO & Co-Founder, Predicta Med, “Autoimmunity – SaaS”
Gali Lerman, PhD, CSO, TAU – Colton Center for Autoimmunity
Manuela Vecsler, PhD, VP Clinical & Scientific Affairs, Ibex Medical Analytics, ” AI in Breast Cancer Diagnosis: from Machine Learning to LIVE Worldwide Clinical Use”
Hadas Ziso, PhD, CEO & Co-Founder, EndoCure, “Robotic AI-powered high-resolution ultrasound imaging for superior endometriosis diagnosis and management”
Dr. David Shashar, MD, CEO & Co-Founder, PregnanTech, “PregnanTech: A game-changing device revolutionizing preterm birth prevention”
Daniella Gilboa, CEO & Co-Founder, AIVF
THURSDAY, MAY 23, 2024
- 10:00 - 10:30 - Plenary: Prof. Yitshak Kreiss, M.D.,Director General, Sheba Medical Center
- 10:30 - 11:00 - Plenary: Eyal Waldman, HDR, Chairman, Waldo Holdings Israel
- 11:00 - 11:30 - Coffee Break
HALL A
11:30 - 13:30
Advancements in the space of bio-convergence
Moderator:
Aviv Zeevi, PhD, Vice President & Director, Technology Infrastructure Division, Israeli Innovation Authority
Keynote: Sharon Shacham, Co-Founder & Managing Partner, E44 Ventures, “How does the biology revolution look in the eyes of entrepreneurs?”
Company Presenters:
Inbar Maymon Pomeranchik, CEO, AgChimedes
Prof. Oded Shoseyov, PI & Serial Entrepernuer, CollPlant
Dganit Vered, CEO, Smart Agro Fund
Michal Levi, PhD, Chief Scientist, Senior Deputy Director General, Ministry of Agriculture and Rural Development
David Zigdon, CEO, MIGAL Galilee Research Institute, “Infrastructure and research: working together”
Dotan Peleg, CEO, ProJini AgChemcompany
Keynote: Neta Agmon, PhD, VP-R&D, AlaGene
Keynote: Ariel Blumovich, CEO, YD Labs
Guy N. Michrowski, CEO, ProFuze Tech, “From the lab to the plate – how the correct use of nutritional supplements and protocols increases the meal and reduces costs?”
Eyal Emanuelle, CSO, Plantae Bioscience
Closing
HALL B
11:30 - 13:30
Digital health role in 2024 and forward
Moderator:
Ittai Harel, Managing Partner, Pitango Venture Capital
Keynotes:
Amir Dan Rubin – CEO & Founding Managing Partner, ex One Medical CEO, Healthier Capital
Udi Goori, General Manager, Carelon Digital Platforms Israel
Company Presenters:
Moran Snir, CEO &
Daniella Gilboa, Ceo & Co- Founder, AIVF
Ronen Lavi, Co-Founder, Navina AI
Dedi Gilad, Co-Founder, TytoCare
Yoni Shtein, Co-Founder, Laguna
Alon Joffe, Co-Founder, Elios
Gal Salomon, Chairman of the board, Clew Medical
HALL C
11:30 - 13:30
Hospital at home: universities ‘and hospitals’ innovations
Moderator:
Avner Halperin, CEO, Sheba Medical Center
Keynote: Dr. David M. Levine, MD,MPH, MA, Practicing General Internist & Clinician-investigator, Brigham Health & Harvard Medical School
Keynote: Dr. Avi (Abraham) Tzur, MD, Senior Physician, Maternal & Fetal Medicine Department, Head Center for Innovation in Women’s Health, Sheba Medical Center-Tel Ha Shomer Hospital
Company Presenters:
Roni Attali, PhD, CEO, AISAP, “Empowering physicians with AI at the-point-of-care”
Ziv Peremen, PhD, CEO, Xtrodes, “Unleashing the full potential of Electrophisiological home monitoring”
Mira Altmark-Sofer, Vice President Marketing, Pulsenmore
Tomer Epstein, Director, Strategic Partnerships, Biobeat, “Transforming mental health treatment with data from deep in the brain”
Avner Rouach, Founding Partner & CEO, CatAI
- 13:30 - 14:30 - Lunch
HALL A
14:30 - 16:30
“From Local Successes to Systemic Scale - BioConvergence Infrastructure Enabling Growth”
Moderator: Dr. Nathalie Bloch, MD, MPA, Senior Advisor, Israeli Innovation Authority, 8400 Network Member
Keynote: Michal Tsur, Co-Founder & Co-CEO, Remepy, “Driving Medical Outcomes Through Hybrid Mechanisms of Action”
Keynote: Prof. Peter Peumans, CTO Health Technologies, imec, “The BioChip Opportunity – imec Case Study ”
Company Presenters:
Dr. Yishay Falick, MD, Director, HealthTech & Bioconvergence, Israeli Aerospace Industry (IAI), “BioConvergence Fueling Dual Use Technologies “
Prof. Ofra Benny, CSO & Director, Pre-Cure, HUJI , “From Tumor on a Chip to Patient on a Chip – Transforming Drug Development”
Chat:
Orly Savion, PhD, Alagene , “The SynBio Opportunity”
Rachela Popvotzer, PhD, Rachela Popvotzer Lab, Bar Ilan University
Company Presenter:
Gideon Lapidoth, PhD, Enzymit, “Enzymit: The New Chemistry of Enzyme Design”
Chat: Irit Carmy Levy, Aummune, The OrganoSphere Opportunity
OrganoSphere Consortium
Eran Seger, Co-Founder & CEO, Protai
Company Presenter:
Oren Caspi, PhD, Principal Investigator, Caspi Lab, CRIR, “Cardiovascular Organoid Maturation”
Prof. Yael Haberman, MD, Associate Professor, Physician-Scientist & Head of Microbiome Center, Sheba Medical Center, “Mini-Gut” Organoids – Determening Causality & New Treatments
Dr. Naomi Podeh Shakked, MD, PhD, Researcher, Pediatric Nephrology, Pediatric Stem Cell Research Institute, Sheba Center for Regenerative Medicine, “Leveraging Human-Based Organoid Models to Decipher Disorders of Kidney Development”
Panel:
Limor Sandach, Venture Advisor, Ex-CEO, AV Medical Technologies
Chen Ben-Dori, CEO, OffRa Health
Tali Ilovitsh, PhD, Principal Investigator, TAU
Amir Minervi, PhD, Deputy Director, Rambam Institute for Pain Medicine
HALL B
14:30 - 16:30
Israeli medical contribution to breakthrough science and technology
Moderators: Dr. Barak Azmon, Director, Pres-By
Company Presenter:
Michael Kardosh, COO, Bionaut Labs
HALL C
14:30 - 15:30
Workshop: Hogan Lovells
Concept, Commercialization, and Beyond: Navigating Through the Company and Product Life Cycle
